Northwest Biotherapeutics, Inc.
NWBO
$0.17
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.69% | -41.25% | -33.33% | 5.65% | 55.31% |
| Total Receivables | -- | -- | 0.00% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -55.19% | 103.88% | -6.92% | 26.54% | -3.57% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -58.50% | 12.42% | -23.35% | 16.95% | 31.35% |
|
|
|||||
| Total Current Assets | -58.50% | 12.42% | -23.35% | 16.95% | 31.35% |
| Net Property, Plant & Equipment | -1.76% | -3.62% | 2.21% | 0.15% | 2.78% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -0.22% | -2.14% | 4,016.72% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -0.56% | -0.56% | -3.24% | 0.82% |
| Total Assets | -5.13% | -1.52% | 165.58% | 3.59% | 7.42% |
|
|
|||||
| Total Accounts Payable | 2.99% | 2.49% | 14.66% | 13.59% | 14.02% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -12.05% | 23.05% | -30.23% | -16.81% | -16.95% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -26.22% | -3.71% | 21.47% | 4.98% | 4.66% |
| Total Finance Division Other Current Liabilities | -10.28% | -56.96% | -9.34% | 12.32% | 0.71% |
| Total Other Current Liabilities | -10.28% | -56.96% | -9.34% | 12.32% | 0.71% |
| Total Current Liabilities | -11.60% | -9.52% | 4.32% | 4.75% | 1.04% |
|
|
|||||
| Total Current Liabilities | -11.60% | -9.52% | 4.32% | 4.75% | 1.04% |
| Long-Term Debt | 13.79% | -9.32% | -43.79% | 38.66% | 14.05% |
| Short-term Debt | -12.05% | 23.05% | -30.23% | -16.81% | -16.95% |
| Capital Leases | -0.82% | -2.72% | -0.81% | -3.83% | 3.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.18% | -1.58% | 774.76% | -63.83% | 0.00% |
| Total Liabilities | -6.26% | -8.34% | 2.39% | 8.33% | 3.42% |
|
|
|||||
| Common Stock & APIC | 0.99% | 0.85% | 3.34% | 1.30% | 1.30% |
| Retained Earnings | -0.61% | -0.20% | 0.09% | -1.81% | -1.05% |
| Treasury Stock & Other | 35.19% | 48.82% | 21.60% | 32.78% | -246.06% |
| Total Common Equity | 10.62% | 16.15% | 44.52% | -8.23% | -0.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -16.71% | -1.78% | -5.15% | -2.57% | -6.07% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -16.71% | -1.78% | -5.15% | -2.57% | -6.07% |
|
|
|||||
| Total Common Equity | 10.62% | 16.15% | 44.52% | -8.23% | -0.91% |
| Total Preferred Equity | -16.71% | -1.78% | -5.15% | -2.57% | -6.07% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.63% | 19.99% | 50.06% | -9.94% | -2.12% |
|
|
|||||